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Abstract
Accumulation and deposition of b-amyloid protein (Ab) are the hallmark features of Alzheimer’s disease. The inhalation
anesthetic isoflurane has been shown to induce caspase activation and increase Ab accumulation. In addition, recent studies
suggest that isoflurane may directly promote the formation of cytotoxic soluble Ab oligomers, which are thought to be the
key pathological species in AD. In contrast, propofol, the most commonly used intravenous anesthetic, has been reported to
have neuroprotective effects. We therefore set out to compare the effects of isoflurane and propofol alone and in
combination on caspase-3 activation and Ab oligomerization in vitro and in vivo. Naı ¨ve and stably-transfected H4 human
neuroglioma cells that express human amyloid precursor protein, the precursor for Ab; neonatal mice; and conditioned cell
culture media containing secreted human Ab40 or Ab42 were treated with isoflurane and/or propofol. Here we show for the
first time that propofol can attenuate isoflurane-induced caspase-3 activation in cultured cells and in the brain tissues of
neonatal mice. Furthermore, propofol-mediated caspase inhibition occurred when there were elevated levels of Ab. Finally,
isoflurane alone induces Ab42, but not Ab40, oligomerization, and propofol can inhibit the isoflurane-mediated
oligomerization of Ab42. These data suggest that propofol may mitigate the caspase-3 activation by attenuating the
isoflurane-induced Ab42 oligomerization. Our findings provide novel insights into the possible mechanisms of isoflurane-
induced neurotoxicity that may aid in the development of strategies to minimize potential adverse effects associated with
the administration of anesthetics to patients.
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Introduction
Alzheimer’s disease (AD) is one of the most common forms of
dementia, which affects 4.5 million Americans and costs more than
$100 billion a year on direct patient care alone. Accumulation and
oligomerization of b-amyloid protein (Ab), tau protein hyperpho-
sphorylation, neuronal loss, synaptic dysfunction, mitochondrial
damage, neuroinflammation, loss of calcium regulation, and other
changes have been shown to contribute to AD neuropathogenesis
(reviewed in [1]). Increasing evidence suggests a role for caspase
activation and apoptosis in AD neuropathogenesis ([2,3,4,5,6,7,8,
9,10,11], reviewed in [12,13]). A recent study by Burguillos et al.
[14] have shown that pro-inflammatory stimuli, e.g., lipopolysac-
charide, can induce the activation of caspase-8, -3 and -7 inside
microglia without causing apoptosis. The activated caspases then
induce microglia activation via the protein kinase C-d-dependent
pathway. In addition, the activated caspases have been found in the
frontal cortex of AD patients. Taken together, these findings suggest
that caspase activation alone without apoptosis may still be able to
contribute to AD neuropathogenesis.
Several studies have shown that the commonly used inhalation
anesthetic isoflurane may induce caspase activation, apoptosis, Ab
oligomerization and accumulation, neuroinflammation, tau protein
hyperphosphorylation, mitochondrial dysfunction, and impairment
of learning and memory ([15,16,17,18,19,20,21,22,23], reviewed in
[24,25]). However, the underlying mechanisms and potential
interventions of these effects remain largely to be determined.
Propofol, the most commonly used intravenous anesthetics, has
been shown to have neuroprotective effects by attenuating caspase
activation and apoptosis [26,27,28,29,30,31,32]. However, the effects
ofpropofolontheisoflurane-inducedcaspaseactivation,aswellasthe
potential underlying mechanisms, have not yet been investigated.
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1In the present studies, we set out to determine the effects of
propofol on the isoflurane-induced caspase-3 activation in human
neuroglioma cells and in the brain tissues of neonatal mice.
Moreover, we performed mechanistic studies to determine
whether propofol can attenuate the isoflurane-induced caspase-3
activation by affecting isoflurane’s effects on Ab oligomerization.
Results
Propofol attenuates the isoflurane-induced caspase-3
activation in H4-APP cells
Several studies have shown that isoflurane can induce caspase
activation [18,19,33,34,35,36,37,38]. The molecular mechanisms
underlying these effects, however, are largely unknown. Moreover,
interventions that could mitigate the isoflurane-induced caspase-3
activation remain largely to be determined. Propofol has been
shown to have neuroprotective effects by attenuating caspase
activation and apoptosis [26,27,28,29,30,31,32]. We therefore
assessed whether propofol can mitigate the isoflurane-induced
caspase-3 activation in vitro (H4-APP and H4 naı ¨ve cells) and in vivo
[neonatal wild-type (WT) and AD transgenic (Tg) mice].
The H4-APP cells were treated with 100 nM propofol or saline
for 10 minutes following by 2% isoflurane or control condition for
six hours. The cells were harvested at the end of the experiment and
were subjected to Western blot analysis. Caspase-3 immunoblotting
revealed that the isoflurane treatment induced caspase-3 activation
(Figure 1A) as evidenced by increased ratios of cleaved (activated)
caspase-3fragment(17 kDa) to full-length (FL)(35–40 kDa)caspase-
3. Treatment with 100 nM propofol alone did not induce caspase-3
activation, but the propofol treatment attenuated the isoflurane-
induced caspase-3 activation (Figure 1A). Quantification of the
Western blots (Figure 1B), based on the ratio of caspase-3 fragment
to FL caspase-3, revealed that isoflurane (black bar) led to caspase-3
activation as compared to the control condition (white bar): 1.00
versus 2.30 fold (P=0.001). The propofol treatment (net bar)
attenuated the isoflurane-induced caspase-3 activation: 2.30 fold
versus1.77fold(P=0.005).Thesefindingssuggestthatpropofolmay
mitigatethe isoflurane-inducedcaspase-3activationinH4-APPcells.
Propofol does not attenuate the isoflurane-induced
caspase-3 activation in H4 naı ¨ve cells
Next, we assessed whether propofol could also attenuate the
isoflurane-induced caspase-3 activation in H4 naı ¨ve cells, which
have less Ab levels than the H4-APP cells. Caspase-3 immunoblot-
ting revealed that the isoflurane treatment induced caspase-3
activation as compared to the control condition in the H4 naı ¨ve
cells (Figure 2A), which is consistent with our previous studies [37].
However, the propofol treatment did not attenuate the isoflurane-
induced caspase-3 activation in the H4 naı ¨ve cells (Figure 2A).
QuantificationoftheWestern blotshowedthatisoflurane (blackbar)
led to caspase-3 activation as compared to the control condition
(whitebar):1.00 versus1.68 fold(P=0.010).Thepropofoltreatment
(net bar) did not attenuate the isoflurane-induced caspase-3
activation: 1.68 versus 1.56 fold. These results showed that propofol
did not mitigate the isoflurane-induced caspase-3 activation in H4
naive cells. Taken together, these findings suggest that propofol may
have different effects in affecting the isoflurane-induced caspase-3
activation between the H4-APP and H4 naı ¨ve cells.
The comparison of the effects of propofol between H4
naı ¨ve and H4-APP cells
Given the observation that propofol may have different effects
when interacting with isoflurane between H4-APP cells and H4
naı ¨ve cells, we next performed studies to assess the effects of
propofol on isoflurane-induced caspase-3 activation in both H4-
APP and H4 naı ¨ve cells at the same time and compare their effects
side by side in the Western blot analysis. We were able to show that
propofol attenuated the isoflurane-induced caspase-3 activation in
H4-APP cells, but not in H4 naı ¨ve cells (Figure S1A and S1B).
The comparison of the effects of propofol between WT
neonatal mice and AD Tg neonatal mice
Next, we performed the in vivo relevance studies by assessing the
effects of isoflurane and propofol on caspase-3 activation in WT
neonatal mice and AD Tg neonatal mice. We chose the neonatal
mice in these experiments because the neonatal AD Tg mice are
less expensive and are easier to obtain than the adult AD Tg mice.
As can be seen in Figure 3A, propofol (lanes 5 and 6) attenuated
the isoflurane-induced caspase-3 activation (lanes 3 and 4) in the
brain tissues of AD Tg neonatal mice. However, the propofol
treatment (lanes 7 and 8) did not attenuate the isoflurane-induced
caspase-3 activation (lanes 1 and 2) in the brain tissues of WT
neonatal mice. Quantification of the Western blot further
illustrated that the propofol treatment (net bar) attenuated the
isoflurane-induced caspase-3 activation in the AD Tg neonatal
mice (black bar): 1.48 versus 0.5 fold, P=0.001 (Figure 3B). In
WT neonatal mice, however, the propofol treatment (gray bar) did
not attenuate the isoflurane-induced caspase-3 activation: 1.00
versus 0.88 fold (Figure 3B). These results from the in vivo studies
further suggest that elevated levels of Ab may potentiate the
isoflurane-induced caspase-3 activation, and the effects of propofol
on attenuating the isoflurane-induced caspase-3 activation are
dependent on the elevated levels of Ab.
In order to rule out the possibility that isoflurane itself might not
be activating caspase-3 above basal levels in WT and AD Tg mice,
we assessed the effects of isoflurane alone on caspase-3 activation
in the mice and we were able to show that anesthesia with 1.4%
isoflurane for six hours induced caspase-3 activation in both WT
and AD Tg mice (Figure S2A, S2B, S2C and S2D).
Propofol attenuates the isoflurane-induced Ab42
oligomerization
Isoflurane has been shown to enhance Ab oligomerization in
cultured cells [17]. iAb5, clioquinol, and congo red, the inhibitors
of Ab oligomerization and aggregation, have been shown to
mitigate the isoflurane-induced caspase-3 activation in cultured
cells [36,37]. Given the observation that propofol can attenuate
the isoflurane-induced caspase-3 activation in the current
experiment, next we asked whether propofol can reduce the
isoflurane-induced Ab oligomerization. The cell culture media
containing secreted human Ab40 or Ab42, which resulted from
the H4 cell overexpressed human Ab40 or Ab42, were treated
with isoflurane and/or propofol for six hours. The media were
harvested at the end of the experiments.
As can be seen in Figure 4A, Ab immunoblotting revealed that the
isoflurane treatment increased Ab42 oligomerization (lane 3) as
compared to the control condition (lane 1). Treatment with 100 nM
propofol alone (lane 2) did not affect Ab42 oligomerization, but the
propofol treatment (lane 4) attenuated the isoflurane-induced Ab42
oligomerization. Quantification of the Western blots (Figure 4B)
showed that the isoflurane treatment (black bar) led to an
enhancement of Ab42 oligomerization as compared to the control
condition (white bar): 100% versus 150% (P=0.00003). The propofol
treatment (net bar) attenuated the isoflurane-induced Ab42 oligomer-
ization: 150% versus 128% (P=0.025). These findings suggest that
propofol may mitigate the isoflurane-induced Ab42 oligomerization.
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treatment (Figure 4C, lane 3) did not enhance the Ab40
oligomerization as compared to the control condition (Figure 4C,
lane 1). Neither the propofol treatment alone (lane 2) nor the
treatment of propofol plus isoflurane (lane 4) affected Ab40
oligomerization as compared to control condition (lane 1)
(Figure 4C). Quantification of the Western blots (Figure 4D)
showed that the isoflurane treatment (black bar) did not enhance
Ab40 oligomerization as compared to the control condition (white
bar). The treatments with propofol alone (gray bar) or propofol
plus isoflurane (net bar) did not affect the Ab40 oligomerization.
Finally, the concentration of Ab40 (4.660.69 ng/ml) was not
significantly different from that of Ab42 (5.360.42 ng/ml),
P=0.090, N.S., in the experiments. Taken together, these findings
suggest that isoflurane may specifically enhance Ab42, but not
Ab40, oligomerization. Propofol can attenuate the isoflurane-
induced Ab42 oligomerization.
Collectively, these results suggest that isoflurane may induce
cytotoxicity via its effects on promoting Ab42 oligomerization,
which are consistent with the findings from other studies
[17,36,37]. Moreover, these results suggest that propofol may
attenuate the isoflurane-induced caspase-3 activation by dimin-
ishing the isoflurane-induced Ab42 oligomerization (Figure 5).
Discussion
The commonly used inhalation anesthetic isoflurane has
previously been shown to induce caspase-3 activation and
apoptosis [18,19,34,36,37,38,39]. The underlying mechanisms
and interventions to attenuate such effects remain largely to be
determined. Propofol, the most commonly used intravenous
anesthetic, has been shown to protect against caspase activation
and apoptosis [26,27,28,29,30,31,32]. We therefore investigated
the effects of propofol on the isoflurane-induced caspase-3
activation in vitro and in vivo, since caspase-3 activation alone,
Figure 1. Propofol attenuates the isoflurane-induced caspase-3 activation in H4-APP cells. A. Treatment with 2% isoflurane (lanes 5 and
6) induces caspase-3 activation as compared to the control condition (lanes 1 and 2). The treatment of propofol alone (lanes 3 and 4) does not induce
caspase-3 activation as compared to the control condition (lanes 1 and 2). However, propofol treatment (lanes 7 and 8) attenuates the 2% isoflurane-
induced caspase-3 activation as compared to 2% isoflurane alone (lanes 5 and 6) in the H4-APP cells. There is no significant difference in amounts of
b-Actin in the H4-APP cells following these treatments. B. Quantification of the Western blot shows that 2% isoflurane (black bar, ** P=0.001) induces
caspase-3 activation as compared to control condition (white bar). The propofol treatment alone (gray bar) does not induce caspase-3 activation as
compared to control condition (white bar). However, two-way ANOVA shows that the propofol treatment (net bar, ## P=0.005) attenuates the
isoflurane-induced caspase-3 activation. (N=3).
doi:10.1371/journal.pone.0027019.g001
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AD dementia and cognitive dysfunction [14].
We have found that propofol can attenuate the isoflurane-
induced caspase-3 activation. Other studies have shown that
isoflurane impairs learning and memory in rodents [15,16,40],
whereas propofol does not [41,42]. Taken together, these findings
suggest that propofol could be preferably used in patients who are
susceptible to cognitive dysfunction, e.g., AD patients and older
adults, pending further studies. Future research may also include
assessing whether isoflurane alone can induce neurotoxicity and
impairment of cognitive function, whereas isoflurane plus propofol
will not, in both animal and human studies.
It is interesting that propofol can only attenuate the isoflurane-
induced caspase-3 activation when levels of Ab are already
elevated (H4-APP cells and AD Tg mice). Other studies have
shown that propofol can maximally attenuate the damage from
cerebral ischemia, via its antioxidant effects, during the time of
reperfusion when free radicals were markedly increased [31].
Thus, it is conceivable that propofol may execute its protective
effects when the damage is high, e.g., elevated levels of Ab and
oxidative stress.
Elevated Ab levels lead to more Ab oligomerization and
aggregation. Isoflurane has been shown to increase Ab accumu-
lation [18,19,37] and enhance Ab oligomerization [17]. In
addition, the inhibition of Ab oligomerization and aggregation
can attenuate the isoflurane-induced caspase-3 activation in
cultured cells [36,37]. Finally, in the current studies we have
shown that propofol can attenuate the isoflurane-induced Ab42
oligomerization. Collectively, we have postulated that one of the
mechanisms by which isoflurane induces caspase-3 activation is to
enhance Ab oligomerization, especially when the Ab levels are
elevated. Propofol may attenuate this isoflurane-induced caspase-3
activation via its ability to reduce the isoflurane-induced Ab
oligomerization.
Figure 2. Propofol does not attenuate the isoflurane induced caspase-3 activation in H4 naive cells. A. Treatment with 2% isoflurane
(lanes 5 and 6) induces caspase-3 activation as compared to the control condition (lanes 1 and 2). The treatment of propofol alone (lanes 3 and 4)
does not induce caspase-3 activation as compared to the control condition (lanes 1 and 2). Propofol treatment (lanes 7 and 8) does not attenuate the
2% isoflurane-induced caspase-3 activation as compared to 2% isoflurane alone (lanes 5 and 6) in the H4 naive cells. There is no significant difference
in amounts of b-Actin in the H4 naive cells following these treatments. B. Quantification of the Western blot shows that 2% isoflurane (black bar,
** P=0.010) induces caspase-3 activation as compared to control condition (white bar). The propofol treatment alone (gray bar) does not induce
caspase-3 activation as compared to the control condition (white bar). Two-way ANOVA shows that the propofol treatment (net bar, P=0.327, N.S.)
does not attenuate the isoflurane-induced caspase-3 activation in the H4 naı ¨ve cells. (N=3).
doi:10.1371/journal.pone.0027019.g002
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propofol itself can increase Ab42 oligomerization [17]. Therefore,
it is possible that the effects of propofol on isoflurane-induced Ab
oligomerization are dose-dependent, and that high concentrations
of propofol may potentiate, whereas low concentrations of
propofol may attenuate, the isoflurane-induced Ab oligomeriza-
tion. Further studies are necessary to test these hypotheses, and to
investigate the potential application of propofol-induced reduction
in Ab oligomerization.
It is also interesting that isoflurane only induced oligomerization
of Ab42, but not Ab40, in the current studies. This observation
may not be due to different concentrations of Ab40 and Ab42,
because we found that there was no significant difference between
the concentrations of Ab40 and Ab42 in the current studies. The
exact underlying mechanisms of these findings remain to be
determined. Previous studies by Yan and Wang [43] showed that
the C terminus of Ab42 is more rigid than the C terminus of Ab40,
and Ab42 may have lower configurational entropy than Ab40 in
the C terminus under physiological conditions. Ab42 would be
easier to oligomerize than Ab40 because the entropic price for
Ab42 to aggregate into fibrils is smaller than that for Ab40.
Therefore, it is conceivable that isoflurane may have more
interaction with the C terminus of Ab42 and less with Ab40,
owing to the greater rigidity of Ab42 and weaker rigidity of Ab40
C terminuses, which leads to more and less (or no) oligomerization
of Ab42 and Ab40, respectively. Furthermore, propofol may
Figure 3. Propofol attenuates the isoflurane-induced caspase-3 activation in AD Tg neonatal mice but not in WT neonatal mice. A. In
WT neonatal mice, the propofol treatment (lanes 7 and 8) does not attenuate the isoflurane-induced caspase-3 activation (lanes 1 and 2). Isoflurane
induces a greater degree of caspase-3 activation in the AD Tg neonatal mice (lanes 3 and 4) as compared to that in WT neonatal mice (lanes 1 and 2).
The propofol treatment (lanes 5 and 6) attenuates the isoflurane-induced caspase-3 activation (lanes 3 and 4) in the AD Tg neonatal mice. B.
Quantification of the Western blot shows that propofol (grey bar) does not attenuate the isoflurane-induced caspase-3 activation (white bar) in the
WT neonatal mice. Isoflurane induces a greater degree of caspase-3 activation in the AD Tg neonatal mice (black bar, * P=0.041) than in the WT
neonatal mice (white bar). In the AD Tg neonatal mice, propofol (net bar, ## P=0.001) attenuates the isoflurane-induced caspase-3 activation (black
bar). (N=3).
doi:10.1371/journal.pone.0027019.g003
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Ab42, leading to attenuation of the isoflurane-induced Ab42
oligomerization. More studies are needed to further test this
hypothesis.
Propofol has been reported to have neuroprotective effects
through activating GABA receptors [27] or by decreasing
glutamate extracellular concentrations [32]. It has been further
suggested that propofol may affect the anti-apoptotic signaling
proteins, including Bcl-2, pAkt, and pERK, to have neuroprotec-
tive effects [29]. Isoflurane has been suggested to induce caspase-3
activation through other mechanisms, e.g., mitochondrial dam-
ages. Therefore, it is also possible that propofol can attenuate the
isoflurane-induced caspase-3 activation via different mechanisms
other than reducing Ab42 oligomerization.
There are several limitations to the current studies. First, in the
in vivo studies, we only assessed the effects of propofol on the
isoflurane-induced caspase-3 activation in neonatal WT and AD
Tg mice, rather than the adult WT and AD Tg mice. This is
because the neonatal AD Tg mice are less expensive and easier to
obtain. Furthermore, we have demonstrated that another
inhalation anesthetic sevoflurane can induce a greater degree of
caspase-3 activation in the AD Tg neonatal mice than in WT
neonatal mice [44]. Second, we did not use several doses of
propofol in the experiments. Rather, we used one dose of propofol
to prove the concept that propofol can attenuate isoflurane-
induced caspase-3 activation. The goal of the animal studies in the
manuscript was to determine the in vivo relevance of the in vitro
findings that propofol may attenuate isoflurane-induced caspase-3
activation in cells with elevated Ab levels (H4-APP cells). The dose
of propofol (200 mg/kg) in animals was equivalent to the dose of
propofol (100 nM) in cultured cells and we found that both the in
vitro and in vivo doses of propofol were able to attenuate isoflurane-
induced caspase-3 activation. Nevertheless, this single dose of
propofol used in the current experiment has allowed us to
Figure 4. Propofol attenuates the isoflurane-induced Ab42, but not Ab40, oligomerization, in conditioned cell culture media. A.
Treatment with 2% isoflurane for six hours (lanes 3) induces Ab42 oligomerization as compared to the control condition (lanes 1). The treatment of
propofol alone (lanes 2) does not affect Ab42 oligomerization as compared to the control condition (lanes 1). However, the propofol treatment (lanes
4) attenuates the 2% isoflurane-induced Ab42 oligomerization as compared to 2% isoflurane alone (lanes 3). B. Quantification of the Western blot
shows that 2% isoflurane (black bar) induces Ab42 oligomerization as compared to control condition (white bar), ** P=0.00003. The propofol
treatment alone (gray bar) does not affect Ab42 oligomerization as compared to control condition (white bar). However, two-way ANOVA shows that
the propofol treatment (net bar) attenuates the isoflurane-induced Ab42 oligomerization, # P=0.002. C. Treatment with 2% isoflurane alone (lanes
3), propofol alone (lane 2) or isoflurane plus propofol (lane 4) do not affect Ab40 oligomerization as compared to the control condition (lanes 1). D.
Quantification of the Western blot 2shows that 2% isoflurane alone (black bar), propofol alone (gray bar) or propofol plus isoflurane (net bar) do not
affect Ab40 oligomerization as compared to control condition (white bar). (N=6).
doi:10.1371/journal.pone.0027019.g004
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27019demonstrate that propofol may attenuate isoflurane-induced
caspase-3 activation in the presence of elevated Ab levels. In the
future studies, we will systemically assess the effects of anesthetics,
including propofol, on AD neuropathogenesis in both WT and AD
Tg mice.
Conclusion
We have found that the commonly used intravenous anesthetic
propofol can attenuate the isoflurane-induced caspase-3 activation
in vitro and in vivo. Moreover, propofol attenuates the isoflurane-
induced caspase-3 activation only in the condition of elevated Ab
levels. Finally, propofol may mitigate the isoflurane-induced Ab42
oligomerization. Collectively, these results suggest that isoflurane
may induce caspase-3 activation via its ability to enhance Ab42
oligomerization and that propofol can attenuate the isoflurane-
induced caspase-3 activation through its ability to mitigate the
isoflurane-induced Ab42 oligomerization. These findings may lead
to more studies aiming at the investigation of the underlying
mechanisms and interventions of potential anesthesia neurotoxic-
ity, which will ultimately provide safer anesthesia care and better
postoperative outcome to patients.
Materials and Methods
H4 naı ¨ve and H4-APP cells
We employed H4 human neuroglioma cells (H4 naı ¨ve cells,
purchased from American Type Culture Collection, Manassas,
VA) and H4 naı ¨ve cells stably-transfected to express full-length
(FL) human amyloid precursor protein (APP) (H4-APP cells) in the
experiments. The H4 naı ¨ve cells were cultured in Dulbecco’s
Modified Eagle Medium (high glucose) containing 9% heat-
inactivated fetal calf serum, 100 units/ml penicillin, 100 mg/ml
streptomycin, and 2 mM L-glutamine. The H4-APP cells were
cultured in the same cell culture supplemented with 220 mg/ml
G418.
Treatments for the H4 naı ¨ve and H4-APP cells
H4 naı ¨ve or H4-APP cells were placed in six well plates with 0.5
million cells and 1.5 ml cell culture media in each well. The cells
were treated with a clinically relevant concentration of propofol
(Diprivan, AstraZeneca Pharmaceuticals, Wilmington, DE),
(100 nM) [32] with or without 2% isoflurane for six hours (air
component: 2% isoflurane, 5% CO2, 21% O2 and balanced
Nitrogen) as described by Xie et al. [19]. Isoflurane was delivered
from an anesthesia machine to a sealed plastic box in a 37uC
incubator. A Datex infrared gas analyzer (Puritan-Bennett,
Tewksbury, MA) was used to continuously monitor the delivered
concentrations of carbon dioxide, oxygen, and isoflurane. Propofol
was prepared in 10% intralipid in DMEM and was administrated
to cells 10 minutes before treatment with isoflurane.
Cell lysis and protein amount quantification
The pellets of the harvested H4 naı ¨ve and H4-APP cells were
detergent-extracted on ice using an immunoprecipitation buffer
(10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5%
Nonidet P-40) plus protease inhibitors (1 mg/ml aprotinin, 1 mg/ml
leupeptin, 1 mg/ml pepstatin A). The lysates were collected,
centrifuged at 13,000 rpm for 15 min, and quantified for total
proteins by a bicinchoninic acid protein assay kit (Pierce, Iselin, NJ).
Mice anesthesia
The animal protocol was approved by Massachusetts General
Hospital Standing Committee (Boston, Massachusetts) on the Use of
Animals in Research and Teaching (Approval ID: 2006N000219).
The anesthesia used on the neonatal mice was similar to that
described by Lu et al. [44]. Specifically, wild-type (WT) mice
[C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME)] and
AD transgenic (Tg) mice [B6.Cg-Tg(APPswe, PSEN1dE9)85Dbo/J,
(The Jackson Laboratory, Bar Harbor, ME)] were distinguished by
genotyping. All animals (3 to 6 mice per experiment) were six days
old at the time of anesthesia and were randomized by weight and
gender into experimental groups that received 1.4% isoflurane in
100%O2 [18] forsix hours in an anesthetizing chamber or a control
group that received 100%O2 [18] for six hours ina similar chamber
with identical flow rate. Saline or propofol [(200 mg/kg, intrapar-
ietal injection (i.p.)] was administered to the mice 10 minutes before
the isoflurane treatment, similarly to the methods described in other
studies [45]. The mice breathed spontaneously, and anesthetic and
O2 concentrations were measured continuously (Datex). The
temperature of the anesthetizing chamber was controlled to
maintain rectal temperature of the animals at 3760.5uC. Mice
were sacrificed by decapitation immediately after the isoflurane
anesthesia. The brainwasremovedrapidlyand the prefrontalcortex
was dissected out and frozen in liquid nitrogen for subsequent
processing for the determination of caspase-3 protein levels.
Brain tissue lysis and protein amount quantification
The harvested brain tissues were homogenized on ice using an
immunoprecipitation buffer (10 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 2 mM EDTA, 0.5% Nonidet P-40) plus protease inhibitors
(1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A). The
lysates were collected, centrifuged at 12,000 rpm for 10 min, and
quantified for total proteins using a bicinchoninic acid protein
assay kit (Pierce, Iselin, NJ).
Western blots analysis
The harvested H4 naı ¨ve, H4-APP cells, and brain tissues were
subjected to Western blot analyses as described by Xie et al. [46].
A caspase-3 antibody (1:1,000 dilution; Cell Signaling Technol-
ogy, Inc.) was used to recognize FL-caspase-3 (35–40 kDa) and
caspase-3 fragment (17–20 kDa) resulting from cleavage at
asparate position 175. Caspase-3 activation is defined as the
quantitative ratio of caspase-3 fragment to caspase-3 full length, as
only this ratio accurately represents the inter-conversion of full
length caspase-3 to cleaved caspase-3, and therefore indicating
caspase-3 activation. The antibody anti-b-Actin (1:10,000, Sigma,
Figure 5. Hypothetical pathway by which propofol attenuates
the isoflurane-induced caspase-3 activation. Isoflurane can
induce oligomerization of Ab42 but not Ab40. The Ab42 oligomer
then causes caspase-3 activation. Propofol inhibits the isoflurane’s
effects on promoting Ab42 oligomerization, leading to the attenuation
of the isoflurane-induced caspase-3 activation.
doi:10.1371/journal.pone.0027019.g005
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the Western blot represents an independent experiment. We have
averaged results from three to six independent experiments. The
quantification of Western blots was performed as described by Xie
et al. [19]. Briefly, the intensity of the signals was analyzed using
the National Institute of Health image program (National Institute
of Health Image 1.62, Bethesda, MD). We quantified the Western
blots using two steps. First, we used levels of b-Actin to normalize
(e.g., determining ratio of FL-caspase-3 amount to b-Actin
amount) levels of caspase-3 to control for any loading differences
in total protein amounts. Second, we presented changes in the
levels of caspase-3 in treated cells or mice as folds of those in cells
or mice in the control condition.
The Ab oligomerization assessment
The H4 Ab40 overexpressed cells and H4 Ab42 overexpressed
cells [47] were placed in different 150 mm cell culture dishes with
10 ml cell culture media. We collected the media 48 hours later,
when the confluence of the cells was about 75%. 1.5 ml of the
media was placed in each well of a six well plate. The media were
treated with a clinically relevant concentration of propofol
(100 nM) [32] and/or 2% isoflurane for six hours. Then, we took
a sample of 75 ml of the conditioned media from each well and
added 25 ml loading buffer [46sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS)+8% beta-mercaptoethanol
(BME)] into the sample. Finally, 10 ml of the mixture of the
sample and loading buffer was loaded and resolved in each lane on
SDS- sodium dodecyl sulfate polyacrylamide gel electrophoresis
(PAGE), transferred to polyvinylidene difluoride membrane (Bio-
Rad Laboratories, Hercules, CA, U.S.A.), fixed with glutaralde-
hyde (1%, vol/vol), probed with the anti-Ab monoclonal antibody
(mAb) 6E10 (1:250) (Covance, Dedham, MA, U.S.A.), and
analyzed for SDS-stable oligomers according to the method of
Atwood et al. [48].
Statistics
Given the presence of background caspase activation in the
cells, we did not use absolute values to describe changes in caspase
activation. Instead, caspase-3 activation (ratio of caspase-3
fragment to caspase-3 full length) was presented as a fold of those
of the control group. One fold of ratio of caspase-3 fragment to
caspase-3 full length refers to control levels for the purposes of
comparison to the experimental conditions. We presented changes
in levels of caspase activation in the treated cells or mice as a fold
of those in the cells or mice after the control condition. Data were
expressed as the mean 6 the standard deviation. The number of
samples varied from three to six, and the samples were normally
distributed. Two-tailed t-test and two-way ANOVA with post-hoc
(Tukey) test [SAS software (Cary, NC, USA)] were used to
compare the differences between groups. P values less than 0.05
(* or #) and 0.01(** or ##) were considered statistically significant.
Supporting Information
Figure S1 Comparison of the effects of propofol on the
isoflurane-induced caspase-3 activation in the H4-APP
cells and H4 naı ¨ve cells. A. In H4 naı ¨ve cells (lanes 1 and 2),
the propofol treatment (lane 2) does not attenuate the isoflurane-
induced caspase-3 activation (lane 1). In H4-APP cells (lanes 3 and
4), the propofol treatment (lane 4) attenuates the isoflurane-
induced caspase-3 activation (lane 3). Isoflurane induces a greater
degree of caspase-3 activation in the H4-APP cells as compared to
that in H4 naı ¨ve cells (lanes 1 versus lane 3). There is no significant
difference in amounts of b-Actin in the isoflurane plus saline or
isoflurane plus propofol-treated H4 naive or H4-APP cells. B. The
quantification of the Western blot shows that propofol (gray bar)
does not attenuate the isoflurane-induced caspase-3 activation
(white bar) in the H4 naı ¨ve cells. However, in the H4-APP cells,
isoflurane induces a greater degree of caspase-3 activation (black
bar, * P=0.042) as compared to that in H4 naı ¨ve cells (white bar),
and two-way ANOVA shows that propofol attenuates the
isoflurane-induced caspase-3 activation in the H4-APP cells (net
bar, ## P=0.004). (N=4).
(TIF)
Figure S2 Isoflurane induces caspase-3 activation in
brain tissues of WT and AD transgenic (Tg) neonatal
mice. A. Isoflurane (lanes 3 to 5) induces caspase-3 activation as
compared to control condition (lanes 1 and 2) in brain tissues of
WT neonatal mice. There is no significant difference in amounts
of b-Actin in the isoflurane or control condition treated-mice. B.
The quantification of the Western blot shows that isoflurane (black
bar, * P=0.012) induces caspase-3 activation as compared to
control condition in brain tissues of WT neonatal mice. (N=4). C.
Isoflurane (lanes 4 to 6) induces caspase-3 activation as compared
to control condition (lanes 1 to 3) in brain tissues of AD Tg
neonatal mice. There is no significant difference in amounts of b-
Actin in the isoflurane or control condition treated-mice. B. The
quantification of the Western blot shows that isoflurane (black bar,
* P=0.045) induces caspase-3 activation as compared to control
condition in brain tissues of AD Tg neonatal mice. (N=4).
(TIF)
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